China spent decades being associated with generic medicines, active pharmaceutical ingredients and low-cost manufacturing. That description is now badly out of date. The more important development for investors is not that China can manufacture drugs cheaply. It is that Chinese companies are increasingly discovering drug candidates, taking them rapidly through early clinical trials and licensing them […]
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Guide Finances 